Insights

Perspective, tips, and resources for moving health forward

All Insights Health Systems Pharmacies Physician Practices Manufacturers Animal Health

AmerisourceBergen

The essential guide to drug commercialization

AmerisourceBergen

February 2023

Pharmacies

DSCSA: Are you ready for November 2023?

Matt Sample

AmerisourceBergen

February 2023

Manufacturers

Three questions biopharma companies must ask when building a cell and gene commercialization strategy

AmerisourceBergen

February 2023

Pharmacies

How are retail prescriptions captured into the 340B program?

David Hardman, Director, 340B Enterprise Strategy and Solutions; Jason Atlas, RPh, MBA, 340B ACE

AmerisourceBergen

January 2023

Manufacturers

What to consider when building a channel strategy for a rare disease product

AmerisourceBergen

August 2022

Channel strategy for a rare disease product

Animal Health

How Destination Pet redefined practice autonomy for its financial benefit

MWI Animal Health

June 2022

Manufacturers

Nine questions about rare and orphan drug commercialization

AmerisourceBergen

February 2022

Manufacturers

Working with government entities to advance access, affordability, and supply chain stability

AmerisourceBergen

December 2021

Manufacturers

Webinar: Rethink your commercialization strategy

Glen Martin; Donna Gilbert; Nancy Hoak

AmerisourceBergen

September 2021

Pharmacies

Four things large retail pharmacies should look for in a distribution partner

Michael Amante

AmerisourceBergen

August 2021

Manufacturers

Webinar: Commercial supply chain strategies for cell and gene therapies

AmerisourceBergen

August 2021

Commercial supply chain strategies for cell and gene therapies

Manufacturers

Webinar | Cell and gene therapies: Clinical supply chain considerations

AmerisourceBergen

August 2021

optimal cell and gene therapy supply chain and tracking outcomes

Animal Health

Managing indirect costs of inventory management in veterinary practices

MWI Animal Health

June 2021

Pharmacies

Five ways distributors should dream big for pharmacy partners

George Rafferty

AmerisourceBergen

June 2021

Manufacturers

Innomar Strategies: 20 years of innovative market access solutions

Innomar Strategies

June 2021

Physician Practices

Supporting flu vaccine access

Tim Navin

April 2021

Manufacturers

On-demand webinar: Success factors for commercializing rare disease and orphan drugs

AmerisourceBergen

April 2021

Commercializing rare and orphan disease products

Manufacturers

The hidden value of integrated commercialization services: A manufacturer’s perspective

AmerisourceBergen

April 2021

Manufacturers

Post-launch checklist: What to look for in a commercialization partner

AmerisourceBergen

April 2021

Manufacturers

Ebook: Strategic partnerships for unlocking product potential

AmerisourceBergen

April 2021

Strategic partnerships for unlocking product potential ebook

Manufacturers

On demand webinar: Considerations for the commercialization of cell and gene therapies

AmerisourceBergen

March 2021

Considerations for the commercialization of cell and gene therapies

Manufacturers

How to make the most of integrated commercialization solutions

Glen Martin

AmerisourceBergen

March 2021

Manufacturers

Ebook: Virtual drug commercialization

AmerisourceBergen

November 2020

Manufacturers

The road to a COVID-19 treatment launch

AmerisourceBergen

October 2020

Manufacturers

Five growth drivers for the consumer healthcare products market

Jessica Donati

Strategic Global Sourcing at AmerisourceBergen

October 2020

consumer scanning products on smartphone in store

Manufacturers

Infographic: navigating health policy

AmerisourceBergen

October 2020

Pharmacies

Spotlight: The corporate partnerships model

George Rafferty

AmerisourceBergen

August 2020

Pharmacies

Driving deeper customer relationships

Michael Amante

AmerisourceBergen

July 2020

Physician Practices

How Community and Specialty Physician Practices Are Confronting COVID-19 Challenges

AmerisourceBergen

June 2020

Pharmacies

How Do Allocations Work for the Pharma Supply Chain?

Heather Zenk, RPh, PharmD

AmerisourceBergen

April 2020

Manufacturers

How the Pharma Supply Chain is Responding to COVID-19

AmerisourceBergen

April 2020

Manufacturers

Preparing for DSCSA Interoperability

Matt Sample

AmerisourceBergen

May 2019

Phase II of DSCSA requires interoperable systems for the electronic tracking of product through the supply chain. Is pharma prepared? Learn what stakeholders need to know and do know to prepare for 2023.

Manufacturers

Rethink: Channel Strategy for Oral Oncolytics

AmerisourceBergen

May 2018

How manufacturers can benefit from provider-led care coordination to improve patient outcomes.

Health Systems

Commercially Available Unit Dose Products: Enhancing Access to Treatments and Promoting Pharmacy Efficiency

Brian McMillan

American Health Packaging

May 2018

While suppliers are making fewer pre-packaged unit dose treatments available, health system pharmacies still have options for acquiring them. Learn which is best.

Manufacturers

A New Approach to Channel Strategy for Oncology Therapies

AmerisourceBergen

April 2018

How is manufacturer thinking around channel strategy changing for oral oncolytics?

Manufacturers

Improving Customer Experience and Driving Long-Term Value for Manufacturers

Rich Tremonte

AmerisourceBergen

August 2017

Rich Tremonte on the current healthcare landscape, the role of the wholesaler and how the new organizational structure at AmerisourceBergen brings out the best in both.

Manufacturers

Changing Channels

Donna Gilbert

Biopharma Services

April 2017

Learn the unintended consequences of channel strategy decisions and the impact on patients and providers.